Edwards appoints new ceo and cfo to drive future growth
The Board of Directors has announced changes to executive management
Nigel Hunton, who has been chief executive for the past four years, will take over the role of chairman with immediate effect.
Matthew Taylor will become ceo and David Smith, cfo. Taylor and Smith, who previously worked together in senior management positions at Jaguar Land Rover (JLR), and Ford Europe, bring extensive international leadership experience to Edwards.
Taylor was most recently the group chief executive officer of JC Bamford Excavators, the market leading global construction equipment company, where he worked from 2006. Previously he spent over 20 years with Ford, culminating in his role as md of Land Rover.
Smith brings 25 years blue-chip international experience with Ford and JLR, the last 13 years in cfo or ceo positions. Following his time as cfo of JLR, he went on to become ceo of the business from 2008-2010, during which time he steered it successfully through the complex ownership transition from Ford to Tata. Prior to JLR, David was finance and business strategy director, Premier Auto Group and Ford Europe.
Edwards employs around 3000 people worldwide in the design, manufacture and support of high technology vacuum and exhaust management equipment, as well as providing a wide range of other pumping technologies and related products. As chairman, Nigel Hunton will continue his active involvement in the business, advising the Board of Directors and the new ceo and focusing in particular on key customers, new product and market opportunities.
The Board is also announcing that, as part of these changes, the current finance director, Chris Bradley, has decided to leave the company. The Board would like to thank Chris for his very strong contribution to the business over the past 8 years.
Nigel Hunton, commented, “I am pleased to welcome Matthew and David to Edwards and look forward to working with them as we continue to deliver success for the company. 2010 is shaping up to be the best year in our 91 year history built on our restructuring actions, new products and new emerging markets. Edwards now has a broader and stronger management team to deliver successfully high technology solutions for our customers and capitalise on opportunities in all our markets”
You may also like
Manufacturing
Lonza appoints Hans Trees as Global Head of Communications
Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
Manufacturing
AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn
AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn
Manufacturing
Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference
By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence
Manufacturing
Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration
CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months
Manufacturing
Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe
After a double-digit million euro investment and less than 1.5 years of construction, SCHOTT Pharma opens new manufacturing site in Jagodina, Serbia. Production capacity to meet European market demand for pharmaceutical ampoules. Facility brings around 180 new jobs to the region
Sustainability
Redefining safety, efficiency, and sustainability: SCHOTT Pharma launches next generation polymer syringe system
A new cap design for prefillable polymer syringes provides tamper evidence at the individual syringe level, significantly reducing the risk of drug waste and ensuring patient safety. The integrated label concept, developed with Schreiner MediPharm, offers reliable first-opening indication, oxygen and light protection, and can include an RFID chip for accurate drug traceability and inventory management. A carton secondary packaging eliminates the need for blister packs, reducing waste and saving valuable storage space in hospitals and during transport, thereby cutting the carbon footprint of the entire value chain by up to 58%